Most Awaited Q3 Sale is back. Upto 30% discount on every report.
RNAi Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 26
SKU : PH4269
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
Multiple User
Enterprise User
Request new version
FAQ’s
What is the Projected CAGR value of the RNAi Therapeutics Market?
The Projected CAGR value is 17.4%.
Who are the key players in RNAi Therapeutics Market?
Key players are Alnylam Pharmaceuticals, Inc, Dicerna Pharmaceuticals, Silence Therapeutics, Arrowhead Pharmaceuticals, Inc, Sanofi, GlaxoSmithKline Plc, Arbutus Biopharma Corporation, Benitec Biopharma, Thermo Fisher Scientific Inc and Sirnaomics, Inc.
Which is the fastest-growing region in the RNAi Therapeutics Market?
Asia Pacific is the fastest-growing region in the RNAi Therapeutics Market.
Which is the Largest Market Share in the RNAi Therapeutics Market?
North America is the Largest Market Share in RNAi Therapeutics Market.
Related Reports
pharmaceuticalsDengue Vaccine Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 20
Starting from
$4350
pharmaceuticalsExocrine Pancreatic Insufficiency Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 May 15
Starting from
$4350
pharmaceuticalsMeningitis Vaccines Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 04
Starting from
$4350
pharmaceuticalsDTaP Vaccine Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 May 10
Starting from
$4350
pharmaceuticalsDNA Vaccines Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 May 11
Starting from
$4350
pharmaceuticalsIon Channel Modulators Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 October 03
Starting from
$4350